Consideration of Commercially Available Hepatocytes as Cell Sources for Liver-Microphysiological Systems by Comparing Liver Characteristics
In recent years, microphysiological systems (MPS) have been developed to shorten the test period and reduce animal experiments for drug development. We examined cell sources for the liver-MPS, i.e., MPS mimicking liver function. For liver-MPS, liver-like cells with high liver functions are required....
Main Authors: | Shinichiro Horiuchi, Yukie Kuroda, Yuji Komizu, Seiichi Ishida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/55 |
Similar Items
-
The perspectives of autologous hepatocytes generation for the treatment of liver failure
by: M. N. Evseeva, et al.
Published: (2015-12-01) -
Development of a Perfusing Small Intestine–Liver Microphysiological System Device
by: Yoko Sakai, et al.
Published: (2023-09-01) -
A transcriptomic dataset comparing two methods of hepatocyte differentiation from human induced pluripotent stem cells
by: Xiugong Gao, et al.
Published: (2022-08-01) -
Distinct hepatocyte identities in liver homeostasis and regenerationKey points
by: Feng Chen, et al.
Published: (2023-08-01) -
Standard operating protocol of hepatic organoid differentiation from human induced pluripotent stem cells
by: Min Jung Kim, et al.
Published: (2022-05-01)